Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the [first new non-opioid painkiller in decades]( ...
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...
The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...
The new drug type targets pathways in the peripheral nervous system before pain signals reach the brain, potentially lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback